Clarence Patrick Machado Insider Trading $AXON Sio Gene Therapies Inc.
Get free email notifications about insider trading for Clarence Patrick Machado.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Clarence Patrick Machado. Clarence Patrick Machado is Director in MEDIVATION, INC. ($MDVN) and Sr. Vice President and CFO in MEDIVATION, INC. ($MDVN) and Director in CHIMERIX INC ($CMRX) and Director in SCYNEXIS INC ($SCYX) and Director in ENDOCYTE INC ($ECYT) and Director in INOTEK PHARMACEUTICALS CORP ($ITEK) and 10% Owner in Arbutus Biopharma Corp ($TKMR) and Director in Principia Biopharma Inc. ($PRNB) and Director in Adverum Biotechnologies, Inc. ($ADVM) and Director in Turning Point Therapeutics, Inc. ($TPTX) and 10% Owner in Axovant Sciences Ltd. ($AXON) and Director in Axovant Sciences Ltd. ($AXON) and 10% Owner in Myovant Sciences Ltd. ($MYOV) and Director in Arcus Biosciences, Inc. ($RCUS) and 10% Owner in Urovant Sciences Ltd. ($UROV).
Clarence Patrick Machado in Sio Gene Therapies Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clarence Patrick Machado: 10% Owner, Director
Holdings: 105,952,381 shares
Current Value: $1,374,202,382
Latest Transaction: Mar 19 2019
$AXON Market Capitalization: $1.28B
$AXON Previous Close: $12.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Clarence Patrick Machado in Sio Gene Therapies Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, TKMR, RCUS, CMRX, ECYT, MDVN, MYOV, PRNB, RCKT, SCYX, AXON, TPTX, UROV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2019 | AXON | Axovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 1.50 | 6,666,667 | 10,000,001 | 105,952,381 | 99.3 M to 106 M (+6.71 %) |
| Dec 20 2018 | AXON | Axovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 1.00 | 10,000,000 | 10,000,000 | 99,285,714 | 89.3 M to 99.3 M (+11.20 %) |
| Jun 07 2018 | AXON | Axovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 1.75 | 14,285,714 | 25,000,000 | 89,285,714 | 75 M to 89.3 M (+19.05 %) |
| Jul 19 2017 | AXON | Axovant Sciences L ... | Machado Patrick | Director | Option Exercise | A | 23.67 | 70,000 | 1,656,900 | 70,000 |
Page: 1